Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.85.2.720PMID 10690882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormone Replacement Therapy

  1999cited by this paper
• Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial.

  1999cited by this paper
• Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group.

  1999cited by this paper
• Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.

  1999cited by this paper
• Heterocycle‐Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure‐Activity Relationships in J774 Macrophages

  1998cited by this paper
• Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs.

  1998cited by this paper
• Cytokines, bone remodeling, and estrogen deficiency: a 1998 update.

  1998cited by this paper
• A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.

  1998cited by this paper
• Semen characteristics and fertility tests required for storage of spermatozoa.

  1998cited by this paper
• Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.

  1997cited by this paper
• Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

  1997cited by this paper
• 7 Hormone replacement therapy

  1997cited by this paper
• Hormone replacement therapy.

  1997cited by this paper
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

  1996cited by this paper
• Three-year follow-up on effects of transdermal estrogen.

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Therapeutic controversy: Estrogen replacement in menopause.

  1996cited by this paper
• Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

  1996influential reference
• Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study.

  1995cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

  1992cited by this paper
• Frequency distributions of tetracycline‐based measurements: Implications for the interpretation of bone formation indices in the absence of double‐labeled surfaces

  1990cited by this paper

• Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

  2025influential citation
• Current and emerging bone resorption inhibitors for the treatment of osteoporosis

  2025cites this paper
• Pilot study of the effect of surgical menopause on bone mineral density and quality in patients with gynecological malignancies

  2024cites this paper
• Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy

  2024cites this paper
• The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part II

  2024influential citation
• Severe atypical iliac wing fracture associated with long-term bisphosphonate use

  2024cites this paper
• Osteopathie und evidenzbasierte Medizin, Teil 2: Kritik an der EBM

  2024cites this paper
• Different Statin Dosages and Their Effects on Osteoporosis

  2024cites this paper
• Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey

  2024cites this paper
• Effect of donepezil on bone metabolism among older adults with Alzheimer's disease.

  2024cites this paper
• The Impact of Progesterone and Estrogen on the Tooth Mobility

  2023cites this paper
• Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools

  2023cites this paper
• Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

  2023cites this paper
• Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis: 2022 update Spanish Society for Bone and Mineral Metabolism Research (SEIOMM)

  2022cites this paper
• Towards an individualised approach to management of osteoporosis

  2022cites this paper
• Guías de práctica clínica en la osteoporosis postmenopáusica, glucocorticoidea y del varón (actualización 2022)

  2022cites this paper
• Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis: 2022 update Spanish Society for Bone and Mineral Metabolism Research (SEIOMM)

  2022cites this paper
• The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density

  2021cites this paper
• Association of bone mineral density and depression in different bone sites and ages: A meta‐analysis

  2021cites this paper
• Mental health clinicians views of summary and systematic review utility in evidence-based practice.

  2021cites this paper
• Osteoanabolic therapy for osteoporosis in women

  2021cites this paper
• Menopausal hormone therapy (MHT): the current thinking, the benefits, and the risks

  2021cites this paper
• Association between Osteoporosis and Previous Statin Use: A Nested Case-Control Study

  2021cites this paper
• Dose-dependent effects of pharmaceutical treatments on bone matrix properties in ovariectomized rats

  2021cites this paper
• Combination and Sequential Osteoanabolic/Antiresorptive Therapy in Osteoporosis Treatment

  2020cites this paper
• Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.

  2020cites this paper
• Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials

  2020cites this paper
• Combination and sequential treatment in women with postmenopausal osteoporosis

  2020cites this paper
• Combined antisclerostin antibody and parathyroid hormone (1–34) synergistically enhance the healing of bone defects in ovariectomized rats

  2020cites this paper
• Newly formed and remodeled human bone exhibits differences in the mineralization process.

  2020cites this paper
• Osteoporosis Treatment: Sequential and Combination Therapy

  2019cites this paper
• Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation

  2019cites this paper
• Local administration with silymarin could increase osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats

  2019cites this paper
• Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review

  2019cites this paper
• Diagnosis of osteoporosis in statin-treated patients is dose-dependent

  2019influential citation
• Drugs for the Treatment and Prevention of Osteoporosis in Postmenopausal Women

  2019cites this paper
• Efficacy and Safety of Bisphosphonates for Postmenopausal Women: A Systematic Review and Network Meta-analysis

  2019cites this paper
• Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration

  2019influential citation
• Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

  2019influential citation
• Hormone therapy for the treatment of postmenopausal osteoporosis: will it soon become a lost art in medicine?

  2018cites this paper
• Combination Anabolic and Antiresorptive Therapy for Osteoporosis

  2018cites this paper
• Osteoporosis: Diagnosis and Management

  2018cites this paper
• The effects of sclerostin antibody plus parathyroid hormone (1–34) on bone formation in ovariectomized rats

  2018cites this paper
• Single-dose local administration of parathyroid hormone (1–34, PTH) with β-tricalcium phosphate/collagen (β-TCP/COL) enhances bone defect healing in ovariectomized rats

  2018cites this paper
• Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

  2018cites this paper
• A Clinical Review

  2017cites this paper
• Decrease of Estradiol and Several Lifestyle Factors, but Not Helicobacter pylori Infection, Are Significant Risks for Osteopenia in Japanese Females

  2017cites this paper
• Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial

  2017influential citation
• Hormonersatztherapie nach WHI-und Million Women Study-Konsequenzen für die Praxis

  2017cites this paper
• Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women

  2017cites this paper
• CLINICAL EVALUATION OF COST EFFICACY OF DRUGS FOR TREATMENT OF OSTEOPOROSIS: A META-ANALYSIS.

  2017cites this paper
• Using Osteoporosis Therapies in Combination

  2017cites this paper
• The 2017 hormone therapy position statement of The North American Menopause Society

  2017cites this paper
• Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.

  2017influential citation
• Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses

  2016cites this paper
• Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis.

  2016cites this paper
• A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.

  2016influential citation
• Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice

  2016cites this paper
• Menopausale Hormontherapie zur Frakturprävention

  2015cites this paper
• Evaluation of relationship between balance parameters and bone mineral density

  2015cites this paper
• Relationship between bone mineral density, its associated physiological factors, and tooth loss in postmenopausal Korean women

  2015cites this paper
• ' s response to reviews Title : Relationship between Bone Mineral Density and Its Related Physiological Factors and Tooth Loss in Postmenopausal Korean Women

  2015cites this paper
• Combination Osteoporosis Therapy with Parathyroid Hormone

  2015cites this paper
• Evidence based medicine: a movement in crisis?

  2014cites this paper
• Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats

  2014cites this paper
• Isoflavones – Extraction and Bioavailability

  2014cites this paper
• Effects of Antiresorptive Drugs on Long Bone Growth, Body Weight Gain, and Serum Lipid Levels in Young Adult Ovariectomized Rats

  2014cites this paper
• Hormone replacement therapy and the prevention of postmenopausal osteoporosis

  2014cites this paper
• Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis

  2014cites this paper
• THE EFFECT OF VARIOUS PATHOLOGIES ON BONE QUALITY

  2014cites this paper
• Controversies in Osteoporosis Antiresorptive for Preventing Bone Loss: When to Use One or Two Antiresorptive Agents?

  2013cites this paper
• Soy isoflavone: The multipurpose phytochemical (Review).

  2013cites this paper
• Prävention der postmenopausalen Osteoporose

  2013cites this paper
• EFFECTS OF OVARIECTOMY AND ANATOMICAL LOCATION ON OSTEONAL ENCROACHMENT IN ADULT CORTICAL OVINE BONE

  2013cites this paper
• Relationship among Bone Mineral Density Reduction, Hearing Loss, and Balance Disorders in Osteoporotic Patients

  2013cites this paper
• Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: evidence for site-specific skeletal effects.

  2013cites this paper
• Epidemiology, radiology and histology of atypical femoral fractures

  2013cites this paper
• Proposed pathogenesis for atypical femoral fractures: lessons from materials research.

  2013cites this paper
• Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture

  2013cites this paper
• EFFECTS OF OVARIECTOMY AND ANATOMICAL LOCATION ON OSTEONAL ENCROACHMENT IN ADULT CORTICAL OVINE BONE

  2013cites this paper
• Relationship between Bone Mineral Density and Balance Disorders in Osteoporotic Patients

  2013cites this paper
• Osteonecrosis of the Jaw and Atypical Femoral Fractures

  2013cites this paper
• Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?

  2013cites this paper
• 13. The Use of Combination Therapy in the Treatment of Postmenopausal Osteoporosis

  2013cites this paper
• The impact of alendronate on bone mineral density of osteoporotic patients.

  2013cites this paper
• Effects of adding alendronate to ongoing hormone therapy on bone mineral density in postmenopausal Korean women: a randomized, double-blind, placebo-controlled clinical trial

  2013cites this paper
• Prävention der postmenopausalen Osteoporose

  2013cites this paper
• A meta-analysis characterizing the dose–response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women

  2012cites this paper
• Systematic review of soy isoflavone supplements on osteoporosis in women.

  2012cites this paper
• The use of combination therapy in the treatment of postmenopausal osteoporosis

  2012cites this paper
• Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β‐thalassaemia presenting with osteopenia‐osteoporosis syndrome

  2012cites this paper
• Do bisphosphonates cause femoral insufficiency fractures?

  2012cites this paper
• Integrated Pharmacometrics and Systems Pharmacology Model-Based Analyses to Guide GnRH Receptor Modulator Development for Management of Endometriosis

  2012cites this paper
• Future directions in osteoporosis therapeutics.

  2012cites this paper
• POSTMENOPAUSAL OSTEOPOROSIS- AN UPDATED REVIEW

  2012cites this paper
• An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw.

  2012cites this paper
• Alendronate

  2012influential citation
• The Effect of Antiresorptives on Bone Quality

  2011cites this paper
• Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis

  2011cites this paper
• Premenopausal osteoporosis, an overlooked consequence of anorexia nervosa

  2011cites this paper